Mitochondria-targeted therapeutics, MitoQ and BGP-15, reverse aging-associated meiotic spindle defects in mouse and human oocytes

Creative Commons License

Al-Zubaidi U., Adhikari D., Cinar Ö., Zhang Q., Yuen W. S., Murphy M. P., ...Daha Fazla

HUMAN REPRODUCTION, cilt.36, sa.3, ss.771-784, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1093/humrep/deaa300
  • Dergi Adı: HUMAN REPRODUCTION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.771-784
  • Anahtar Kelimeler: aging, oocyte, spindle, chromosome, mitochondria-targeted therapeutics, ASSEMBLY CHECKPOINT, ANTIOXIDANT MITOQ, HUMAN ANEUPLOIDY, MATERNAL AGE, DOUBLE-BLIND, FERTILITY, SUPPLEMENTATION, COENZYME-Q10, DYSFUNCTION, INFERTILITY
  • Ankara Üniversitesi Adresli: Evet

Özet

STUDY QUESTION: Do mitochondria-targeted therapies reverse ageing- and oxidative stress-induced spindle defects in oocytes from mice and humans?